Stempel DA et al: Serious asthma events with fluticasone plus salmeterol versus fluticasone alone. N Engl J Med 2016;374:1822.
Stempel DA et al: Safety of adding salmeterol to fluticasone propionate in children with asthma. N Engl J Med 2016;375:840.
Barnes PJ: Theophylline. Am J Respir Crit Care Med 2013;188:901.
Rabe KF: Roflumilast for the treatment of chronic obstructive pulmonary disease. Expert Rev Respir Med 2010;4:543.
Guevara J et al: Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma. Cochrane Database Syst Rev 2006; 2:CD003558.
Barnes P: How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 2006;148:245.
Beasley R et al: Combination corticosteroid/beta-agonist inhaler as reliever therapy: A solution for intermittent and mild asthma? J Allergy Clin Immunol 2014;133:39.
Boushey HA et al: Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005;352:1519.
Suissa S et al: Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332.
D’Amato M et al: Anticholinergic drugs in asthma therapy. Curr Opin Pulm Med 2016;22:527.
Lee AM, Jacoby DB, Fryer AD: Selective muscarinic receptor antagonists for airway diseases. Curr Opin Pharmacol 2001;1:223.
Peters SP et al: Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010;363:1715.
Calhoun WJ: Anti-leukotrienes for asthma. Curr Opin Pharmacol 2001;1:230.
Laidlaw TM et al: Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood 2012;119:3790.
Wang L et al: Cost-effectiveness analysis of fluticasone versus montelukast in children with mild-to-moderate persistent asthma in the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2011;127:161.
Busse WW et al: Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011;364:1005.
Walker S et al: Anti-IgE for chronic asthma in adults and children. Cochrane Database Syst Rev 2006;2:CD003559.
Fainardi V, Pisi G, Chetta A: Mepolizumab in the treatment of severe eosinophilic asthma. Immunotherapy 2016;8:27.
Walsh GM: Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma: an update. Expert Rev Clin Immunol 2017;13(2):143.